Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2020 Oct 9.
Published in final edited form as: Nano Lett. 2019 Sep 13;19(10):7526–7533. doi: 10.1021/acs.nanolett.9b03411

Controlling ERK Activation Dynamics in Mammary Epithelial Cells with Alternating Electric Fields through Microelectrodes

Liang Guo †,, Houpu Li ‡,, Yuan Wang , Zhuo Li #, John Albeck §, Min Zhao †,∥,*, Quan Qing ‡,⊥,*
PMCID: PMC6786939  NIHMSID: NIHMS1051685  PMID: 31487192

Abstract

Amplitude, duration, and frequency of activation of the extracellular-signal-regulated kinase (ERK) pathway code distinct information to instruct cells to migrate, proliferate, or differentiate. Synchronized frequency control of ERK activation would provide a powerful approach to regulate cell behaviors. Here we demonstrated modulation of ERK activities using alternative current (AC) electric fields (EFs) applied through high-k dielectric passivated microelectrodes. Both the amplitude and frequency of ERK activation can be precisely synchronized and modulated. ERK activation in our system is independent of Faradaic currents and electroporation, thus excluding mechanisms of changes in pH, reactive oxygen species, and other electrochemical reaction. Further experiments pinpointed a mechanism of phosphorylation site of epidermal growth factor (EGF) receptor to activate the EGFR-ERK pathway, and independent of EGF. AC EFs thus provide a powerful platform for practical and precise control of EGFR-ERK pathway.

Keywords: ERK pathway, EGFR, electric field stimulation, microelectrode

Graphical Abstract

graphic file with name nihms-1051685-f0001.jpg


The ERK signaling pathway regulates critical cell behaviors, including, for example, cell motility, survival, proliferation, and fate determination/differentiation.19 Aberrant signaling of this pathway underlies many important diseases, including cancer and diabetes.10,11 How are such diverse consequences coded by ERK activation? Recent advances in imaging the dynamics of ERK activation with single cell resolution have started to reveal critical coding mechanisms and rich information embedded therein. For example, the decision to enter S phase and proliferation of mammary epithelial cells (MCF10A cells) is influenced by the frequency of ERK activation.1 The change in ERK dynamics in PC12 cells modulated by different pulsed EGF stimulations can decide whether they proliferate or differentiate into neuron-like cells.8,9 In addition, the critical roles of ERK activation dynamics in vivo have also been demonstrated. In mouse epidermis, upon injury, ERK activation propagates as waves in parallel to the wound edge and is associated with G2/M cell cycle progression.12 In C. elegans development, Ras-mediated cell fate specification involves different spatiotemporal pulses of ERK activation.13

A practical method to control the frequency as well as amplitude of ERK activation will be of great value in both basic research as well as possible clinical applications. Frequency modulation (FM) of ERK activation has been achieved with optogenetics, where genetically modified light sensitive molecules are expressed in target cells and light signals are shined at controlled frequency upon cells.14 Another method of FM is through pulsed stimulation with EGF (epidermal growth factor) in which addition and washout of EGF is repeated at required frequency.8,15

We report here a method of frequency modulation of ERK activation that does not require repeated addition and washout of chemicals or genetic-modification of cells. We used an alternating current (AC) electric field (EF) stimulation to induce defined FM of ERK activation. We show that time-modulated symmetric bipolar AC EF of tens of kHz can directly trigger highly localized and synchronized ERK activation without Faradaic process. We provide evidence for selective AC EF induced ligand-independent EGFR phosphorylation. Our work suggests a new strategy and practical technology of precise ERK modulation with high spatial resolution and temporal control and may have significant implications for design of electroceuticals to regulate important biological processes and treat diverse diseases through FM of intracellular signaling pathways.

First, we briefly introduce the ERK activation reporter used in our experiment and the design of the microelectrode chip. ERK translocation reporter (ERKTR) can be used to report activation dynamics of ERK in a spontaneously immortalized mammary epithelial cell line (MCF10A).16,17 Upon activation of EGFR-Ras-ERK pathway, the mCherry-labeled ERKTR is phosphorylated and translocated from the nucleus to the cytosol, causing fluorescence intensity decrease in the nucleus region and increase in the cytosol (Figure 1a). The ratio of fluorescence intensity in the cytosol (Fc) and that in the nucleus (Fn), i.e., ERKTR ratio, thus gives a quantitative in situ assessment of ERK activation of an individual cell with high temporal resolution (see Supporting Information, Materials and Methods). With this real-time reporting system, we ask two questions: (1) How precisely in space and in time can we control ERK activation with EF? (2) What is the possible mechanism that EF couples with the ERK signaling pathways?

Figure 1.

Figure 1.

Reporter cell and chip design. (a) Schematic of ERK translocation reporter (ERKTR, pink color) translocate from the nucleus to cytosol upon activation of EGFR-Ras-ERK signaling pathway. (b) Left: overall microelectrode arrays on the glass coverslip. Right: optical image of one pair of microelectrodes at the center of the chip. The white arrows mark the metal connections that are passivated by 500 nm thick SU-8 polymer. The black arrows mark the exposed parallel microelectrodes. Scale bars: left, 5 mm; right, 200 μm. (c) Waveform of the bipolar electric pulses applied to the electrodes. (d) Left: photo of the assembled cell chamber on the chip and printed circuit board (PCB). Scale bar: 10 mm. The yellow dash line marks the position of the cross-section shown on the right. Right: Schematics of the cross-section structure of the chamber.

To address these questions, we prepared customized microelectrode chips to deliver local EF to the cells with several key considerations: (1) A pair of microelectrodes were used to interface with the cells so that the EF was localized close to the electrodes and decayed rapidly outside the vicinity. The electrodes were fabricated by top-down lithography on a 170 μm thick glass coverslip. The metal connections were passivated by a layer of SU-8 epoxy by photolithography, leaving only the parallel electrode bars exposed, which had an edge-to-edge distance ranging between 50 to 200 μm (Figure 1b). (2) Bipolar symmetrical electric pulses were used in our experiments to eliminate net direct current (DC) ionic flows in the system. Specifically, due to the small exposed surface area of the electrodes, the electric signals were coupled to the medium capacitively as through a high-pass filter with an impedance of ~120 Ω, at 50 kHz (See SI Appendix). The designed signal has fast rising and falling edges and a width of 10 μs to enhance the potential drop within the medium (Figure 1c). (3) The electrodes and circuits connected to them were isolated from all other grounds. We have performed cyclovoltammetry on these electrodes in the assay medium, and there was no significant redox current in a slow voltage sweep between −1.0 and 1.0 V (see Supplementary Figure S1a). In addition, the stability of the electrodes was tested with prolonged application of up to ±1.5 V bipolar pulses for >1 h, and no degradation of the metal surface was observed (see Supplementary Figure S1b). The simulation of the EF distribution (COMSOL Multiphysics, see Supporting Information, Materials and Methods) showed that when an AC (1 V, 50 kHz) was applied between a pair of metal electrodes 200 μm apart in homogeneous medium, the EF strength close to the surface of the substrate and at the center of the electrode pair was ~8 V/cm, and close to the edge of the electrode ~24 V/cm (see Supplementary Figure S2). (4) The chip was assembled into an observation chamber with a thin fluidic channel over the electrode arrays (W 0.5 cm × L 1.0 cm × H 170 μm) where cells were plated and cultured. After wire bonding, the chamber can be mounted on an inverted microscope for imaging as EF stimuli were applied (Figure 1d) (see Supporting Information, Materials and Methods).

Second, we studied the localized activation of ERK by AC EFs on our platform. About 3–6 min after onset of stimulation, fluorescence intensity of the nuclei started to decrease and fluorescence intensity of cytosol increase, indicating ERK activation. Figure 2a is a typical image taken at 9 min after the EF stimuli delivery. The majority of cells close to the electrodes demonstrated clear ERK activation (Figure 2b). Cells more than 200 μm away from the electrode region remained silent, including those that were close to the SU-8 passivated connections (Figure 2c).

Figure 2.

Figure 2.

Localized ERK activation by AC EF. (a) AC EF induced localized ERK activation between a pair of microelectrode bars (marked by the arrows). (b,c) Cells between the microelectrodes (b) and in an adjacent area (c) before and after onset of stimulation. The color-coded images on the right of each panel show the difference of fluorescence intensity before and after stimulation. Blue and orange colors mark areas where the fluorescence intensity decrease and increase, respectively. (d) Time traces of ERKTR ratio of individual representative cells and population average from 164 cells within 100 μm from the electrode. Average data are presented as mean (thick blue line) ± SD (light shadow). Black arrow denotes the time of applying AC-EF, and red line indicates the sustained EF stimuli. (e) Time traces of ERKTR ratio of individual representative cells and population average from 160 cells within the region of 200 to 700 μm away from the electrode. Data are presented as mean (thick blue line) ± SD (light shadow). Black arrow denotes the time of applying AC EF, and red line indicates the sustained EF stimuli.

ERK activation indicated by the ERKTR ratio (Fc/Fn) demonstrated synchronized initial response with heterogeneous dynamics for cells resided within 100 μm from the electrodes. Before onset of EFs, only very few display limited low-level spontaneous ERK activity. About 9 min after onset of the stimulation, cells showed ERK activation with different amplitude and duration (Figure 2d). Majority of the cells showed response between 6 to 18 min following onset of the stimulation. Under continuous EF exposure, the ERK activation level of the majority of cell population gradually decreased toward the baseline in 29 ± 13 min. Cells that are far away from the open electrode area showed no ERK activation by EF (Figure 2e). The heat maps summarizing the ERK activation in both areas are given in Supplementary Figure S3.

We note that activation of ERK is highly localized: more than 80% of cells within the range of 50 μm from the electrodes showed clear ERK activation, and the ratio decreased rapidly to below 20% as the distance increased to more than ~100 μm. Very few cells showed ERK activities 300 μm away from microelectrodes (see Supplementary Figure S4). In addition, under extended EF stimulation, oscillatory patterns in the ERK level could be observed for a small portion of the cells (Figure 3a,b). The peaks and valleys of all the ERKTR ratio time traces were identified using a threshold method automatically (see Supporting Information, Materials and Methods). About 20% of cells showed ERK activation cycles of two times or more (Figure 3c).

Figure 3.

Figure 3.

ERK oscillations under sustained AC EF stimulation. (a) Three cells showing oscillation of ERK under continuous AC EF stimulation. Fluorescent images taken at 0, 10, 20, 30, 40, 50, and 60 min as continuous AC EF stimuli were applied. Cells circled in orange, blue, and green all demonstrated repeated pulsatile ERK activation. Scale bar: 20 μm. (b) Time traces of the ERKTR ratio of the three cells in panel (a), peaks (ERK active) and valleys (ERK at rest) were identified. The black arrow denotes the start time of EF stimulation and red line marks the sustained EF stimuli (c) Peak time map of the 164 cells in Figure 2D under sustained AC EF stimulation. Thirty-five cells showed multiple peaks (≥2) in 3 h. The black dashed line indicated the time of exposure to AC EF stimulation.

Third, we show that no Faradaic process or electroporation were involved in the AC EF activation of ERK, and neither Ca2+ nor reactive oxygen species (ROS) mediated this process. To exclude the possibility of ERK activation related to cell damage,18 we investigated the possibility of cell membrane damage using membrane impermeable dyes. Sytox orange (50 μM, Invitrogen), which stains the nucleus and cannot penetrate intact cell membrane, was added in the medium, and AC EF stimulation was continuously applied for >1 h. Except for very few cells that were in direct contact with the metal electrodes, almost all the cells remained unstained, suggesting no membrane damage (see Supplementary Figure S5a,b). In addition, cells were stained using Cell Viability Imaging Kit (Cat#R37609, Life Technologies, see Supporting Information, Materials and Methods), 2 h after confirming the reproducible ERK activation. More than 95% of the cells remained alive and healthy after the experiment. We also calculated the proliferation rate of cells 24 h after confirming EF activation of ERK as 1.26 ± 0.11, which has no significant difference to the ratio 1.22 ± 0.14 obtained from control groups (see Supporting Information, Materials and Methods, Figure S6).

To exclude any electrochemical reactions that could interfere with the EF activation of ERK, we added an extra layer of high-k passivation over the terminal electrode surface, which blocks all redox reactions while not increasing the impedance of the electrodes significantly (see Supporting Information Text, Supplementary Figure S7a,b). Specifically, we deposited over the entire surface of the chip 10 nm HfO2 by atomic layer deposition (ALD). Cyclic voltammetry test (see Supporting Information, Materials and Methods) confirmed that the HfO2 coating completely suppress the Faradaic process (see Supplementary Figure S7c). Our impedance analysis shows that the capacitive impedance of the added HfO2 layer at 50 kHz is about 7 kΩ, which is comparable to the resistance of the medium layer between the electrodes (see SI Appendix). With this new design of passivated electrodes, we showed that ERK can still be reliably activated by EF stimuli (see Supplementary Figure S7d), with an expected higher threshold pulse amplitude (typically between 1.5—3 V) due to the increase of the impedance. In addition, we have confirmed that neither Ca2+ chelator (BAPTA AM, 3 μM, Life Technologies) nor ROS quencher (Trolox, 350 μM, Sigma-Aldrich) could block the EF activation of ERK (see Supplementary Figure S8), which also suggests that ERK activation in our system is unlikely mediated by Ca2+ changes or ROS, contrary to previously suggested mechanism when DC EF stimulations were applied.19,20 The observed activation of the ERK thus was not associated with redox processes at the electrode interface.

Fourth, we demonstrate that no local temperature increase or diffusion limited process was involved in the activation or ERK We measured the local temperature by tracking the current of a patch clamp pipet electrode before and after the application of AC EF.21 A patch clamp pipet freshly prepared by a micropipette puller (P-1000, Sutter Instruments, see Supporting Information, Materials and Methods) was filled with 0.1 M KCl, giving a typical resistance of 7–10 MΩ. The tip of the patch clamp pipet was positioned within 10 μm above the substrate between the electrodes in a clean chamber by a micromanipulator (MP-225, Sutter Instruments), using Ag/AgCl sealed in 0.1 M KCl as the reference electrode through a salt gel bridge. The room temperature was regulated at 21.6 ± 0.2 °C. A bias of 10 mV was applied to the pipet electrode as the current was monitored through a patch clamp amplifier (HEKA EPC 800 USB). Since the current will be sensitive to the local temperature at the very opening of the pipet, we can use the current to evaluate the local temperature changes. Ten groups of measurements were performed for 3 and 10 min of AC EF stimulations each. When bare Au microelectrodes were used, the calculated temperature change was 0.00 ± 0.05 and 0.01 ± 0.07 °C, respectively, and 0.03 ± 0.07 °C and 0.01 ± 0.05 °C, respectively, when HfO2 coated microelectrodes were used (see Supplementary Figure S9). Therefore, we conclude that there was no appreciable local temperature increase due to the application of AC EF stimulations in our setup in the course of the ERK activation. In addition, we exposed the MCF10A cells to different temperatures between 35 and 39 °C, and the spontaneous ERK activities were most active between 35 to 37 °C. Cells demonstrated much reduced spontaneous ERK activities at higher temperature (see Supplementary Figure S10). These data suggest that local temperature increase was not involved in the observed ERK activation.

In addition, we have studied the onset time of the ERK response for cells at different distances (0–100 μm) from the electrodes. Cells have overall shown clear timing variations in their responses such that the onset time of the ERK activation scattered in a wide range from 6 min up to 36 min (see Supplementary Figure S11). Interestingly, more than 79% cells (n = 216) were activated within 15 min independent of where they were, which strongly suggested a direct interaction with the AC EF. However, <21% of the cells, all of which were >25 μm away from the electrodes, showed 18–36 min onset time that appeared rather randomly distributed, which could be attributed either to spontaneous activities or a diffusion-related process, for example, intercellular communications. In addition, if Joule heating related process were involved, since the current density was higher where it was closer to the electrodes, more pronounced temperature changes would happen faster near the electrodes and slower at farther distance, which was not observed from the onset time distribution. Therefore, this result also suggested that temperature change was not an important factor.

Fifth, we demonstrate that the ERK activation can be precisely synchronized and modulated by AC EFs. Given the localization and synchronized onset of the ERK activation by AC EF, it is therefore possible to control the frequency of the ERK activation for a selected population of cells simply by cycling AC EF on and off with the right timing. As an example, we have achieved very robustly synchronized and enhanced ERK activation at a rate of about twice per hour. Specifically, in one cycle, a 3 min train of bipolar pulses was delivered to the electrodes, during which time no cell response generally has started to appear yet, followed by a ~40 min period in which the EF is turned off. This cycle was repeated for three times in the experiment (see Supplementary Figure S12). Three activation events are readily observed 3–6 min following the AC EF stimuli at 0 min, 48 min, and again 93 min as shown in Figure 4a. The time traces of the ERKTR ratio showed three distinct activation peaks (Figure 4b), which are also evident in the heat map plot (see Supplementary Figure S13) and peak time map (Figure 4c). We noticed that if the duration of EF stimulation in each cycle is reduced shorter than 3 min, we observed less reproducible ERK activation in much fewer cells. In addition, since the time interval of our image sequence is currently limited to 3 min, the selected snapshots might not capture the maximum response of all cells.

Figure 4.

Figure 4.

Repeated short AC EF stimulation induced synchronized ERK activation. (a) Fluorescent images of cells before (left) and after (middle) the 3 min long AC EF stimulations started at 0, 48, and 93 min. Right: Color coded intensity difference. Blue and orange colors mark areas where the fluorescence intensity decreased and increased, respectively. Scale bar: 50 μm. (b) Time traces of ERKTR ratio from individual representative cells and population average from 17 cells. The short red lines mark the duration of EF stimuli. Data are presented as mean (thick blue line) ± SD (light shadow). (c) Peak time map of ERK activities.

From Figure 4, we can see that ~50% of the cells within 100 μm range from the electrodes showed repeated ERK activation by all three short stimulations, while ~30% cells started responding either after the second or the third one. All cells restored to its low ERK level state within an average time of 15 ± 6 min. Interestingly, later stimulation induced more cells to respond in a synchronized manner. These results show that we can precisely synchronize the ERK activation with specific frequency by a minimal duration of localized AC EF stimulation.

Last, we show that the phosphorylation site of EGFR is the target of AC EF to activate ERK Since we can exclude the involvement of electroporation, pH change, ROS and Ca2+, and temperature fluctuations, how did AC EF induce the ERK activation? To determine the detailed mechanism, we systematically inhibited various elements of EGFR-ERK signaling pathway. The canonical EGF-Ras-ERK signaling pathway is initialized by the binding of EGF to the EGFR, which triggers the dimerization and phosphorylation of EGFR, leading to Raf-MEK-ERK signaling (Figure 5a).22,23 We first applied the MEK inhibitor, trametinib (0.5 μM, Selleck Biochemicals), to the cells when trying to activate ERK using either AC EF (Figure 5c, left columns) or with EGF as comparison (Figure 5c, right column). In both cases, we observed inhibition of the ERK activation. Similarly, the Raf inhibitor, sorafenib (20 μM, Biotang), also abolished ERK activation under both stimulation scenarios (Figure 5d). In addition, several small molecule tyrosine kinase inhibitors (TKIs) that bind to the intracellular tyrosine kinase domain of the epidermal growth factor receptor family (ErbB) family of receptors, including the irreversible pan-ErbB inhibitor, afatinib (5 μM, Selleck Biochemicals), which covalently binds to EGFR, HER2, and HER4,24 and the reversible EGFR selective inhibitors, erlotinib (2 μM, Selleckchem) and gefitinib (50 μM, Selleckchem),24 was tested, respectively. In all cases, the ERK activities were silenced under EF stimulation (Figure 5eg, respectively). Surprisingly, however, when EGFR antibody cetuximab (100 μg/mL, ERBITUX) was used just to block the extracellular EGF binding site to the EGFR but leave the phosphorylation site intact, the AC EF could still activate ERK, although with an overall reduced contrast in the fluorescent signals (Figure 5h). These were in sharp contrast to the tests with EGF stimulation controls where both TKIs and EGF antibody blocked ERK activation by EGF stimulations (control groups in Figure 5bh). The time evolution of the ERKTR ratios in all blocker tests under EF stimulation are summarized in Figure 5i, where we can see that the only trace showing ERK activation other than the blank control was the case where EGFR antibody were applied. We also note that for EGF antibody tests, a small retardation in time was often observed. The heat maps of the ERKTR ratio from all recorded cells are summarized in Supplementary Figure S14. These results strongly suggest that the coupling between EF and ERK specifically followed the EGFR-Ras-ERK signaling pathway, initialized by EF-induced EGF-independent kinase activity of EGFR.

Figure 5.

Figure 5.

Blocker tests following the EGFR-Raf-ERK signaling pathway. (a) Schematics of the EGF-Ras-ERK signaling pathway and the blocked sites, including the extracellular EGF binding site, the intracellular phosphorylation site of EGFR, Raf, and MEK. (b–h) (images on the left group) Fluorescence images of cells before and after AC EF stimulation, and the intensity difference; and (images on the right group) fluorescence images of control groups stimulated by EGF chemical stimulation (2 ng/mL), when no inhibitors were applied (b), and with MEK inhibitor trametinib (0.5 μM) (c), Raf inhibitor sorafenib (20 μM) (d), tyrosine kinase inhibitors afatinib (5 μM) (e), erlotinib (2 μM) (f), gefitinib (50 μM) (g), and EGFR binding-site antibody cetuximab (100 μg/mL) (h), respectively. Scale bars: 25 μm. (i) Time traces of ERKTR ratio as population average from cells under AC EF stimulations in panels (b–h). Mean and ±95% CI are shown as a solid line and shadow region, respectively (n >100 cells for each group).

Precise modulations of the magnitude and the frequency/duration of ERK activity are fundamentally significant as both can impact the physiological outcome of ERK signaling in subtle, yet critical ways.1825,26 Compared to chemical methods that usually have poor control in temporal and spatial resolution, our result of AC EF activation of ERK has its unique advantages as the spatial distribution and timing of EF can be engineered to accurately localize and synchronize events at the single-cell level. We have shown that AC EF can induce synchronized ERK activation under continuous stimulation (Figures 2 and 3), and more importantly, provide precise control of ERK dynamics (Figure 4). It is therefore possible to accurately modulate the location, time, frequency, amplitude, and duration of ERK activities by localized AC EF, without the requirement of genetic manipulation as in the case of optogenetics,14 or addition and washout of chemicals.8

To date, investigations on how external EF couples with the ERK signaling pathways have all been focused either on direct-current (DC) and low frequency EF (several hundred Hz), or fast nanosecond pulses and high frequency radiations (several GHz). For example, Wolf-Goldberg et al. showed that low frequency unipolar EF pulses (~500 Hz) applied through bare Pt electrodes in solution can cause ligand-independent activation of epidermal growth factor (EGF) receptor (EGFR), leading to ERK activation,19 where the pH changes and ROS due to electrochemical process at the electrode interface were identified as the possible cause. In addition, nanosecond pulses have been shown to activate p38, c-Jun N-terminal kinase (JNK), and ERK signaling pathways,27,28 which was attributed to cell membrane electroporation and cytosolic Ca2+ level changes due to the EF stimulation. Furthermore, Sheikh et al. showed that microvascular endothelial cells that were exposed to 24 h of high frequency EF (7.5 GHz) demonstrated enhanced ERK phosphorylation, among several other processes, where cRaf/MEK and Ca2+ pathways were involved.

Several major differences between our study and existing approaches should be highlighted. First, we used bipolar symmetric EF pulses with high-k dielectric passivated electrodes designed to eliminate Faradaic processes. This avoids possible biochemical complications and possible detrimental effects known that can happen to living cells and tissues with other techniques, where DC, unipolar, or asymmetric EF were typically coupled to the cells through a low impedance metal interface in direct contact with the medium. We have, for the first time, clarified that intermediate ion flows and chemical species generated by electrochemical processes are not required for EF coupling with ERK signaling pathway. Second, no strong perturbation of the cell integrity was observed in our experiments (see Supporting Information, Materials and Methods) due to the low EF strength, and the main frequency component of the EF (~50 kHz) falls in a middle range that has not been investigated before. Third, we have identified that AC EF can induce EGF-independent phosphorylation of EGFR, which triggers the ERK signaling pathway. Although ligand-independent EGFR phosphorylation has been observed previously with bias applied through low-impedance Pt electrodes in contact with the medium, where ROS and decrease in pH were found to be the cause,19 however, here we have shown that no electrochemical processes are involved in our study.

Using oscillating EF to tune membrane protein activities has been studied in Na–K pump systems.29 Specifically, it has been shown that when the frequency of the external EF matches the natural pumping rates of Na–K pumps (~50 Hz), individual pumps with initially different pumping rates and random pumping phases can be synchronized to generate enhanced transepithelial potential (TEP), due to field-induced energy changes in the ion-transports. However, in our case, the EGFR is not electrogenic and should not be sensitive to ion gradients, and the time scale of the EF pulses (10–20 μs) is obviously much faster in comparison to the operation time of ion pumps. More importantly, the comparison between AC EF-induced and EGF-induced ERK activation in our blocker tests (Figure 5) revealed an intriguing difference, that the extracellular EGFR antibody could only block the EGF stimulation but not the AC EF. This indicates that the AC EF could directly induce the EGFR phosphorylation without requiring EGF binding. To our knowledge, those results are the first demonstration of such unusual possibility, in addition to cases where EGFR can be “transactivated” through ligands binding to other receptors.30 Our data suggest that there could be a new type of direct interaction between AC EF in this frequency range and membrane proteins such as EGFR. A possible explanation is that the spatial distribution of AC EF can be concentrated across the membrane of live cells in a frequency-dependent manner, which could modulate electrostatic interactions at the right time-scale in favor of functional conformation changes of proteins.31 We estimated the transient transmembrane voltage during one-half phase of the AC EF to be between 0.1 and 16 mV (see Supplementary Figure S15), which is consistent with the calculations by Taghian et al.32 While this might potentially bring physiological response from the cells, we note that our AC EF is completely symmetrical around 0 V with very fast switching time of 20 μs. And the whole process of AC EF activation of ERK signaling pathways is as short as 3–20 min. It is unlikely that what we observe is a response to membrane potential, which typically happens in a much longer time scale.33 In addition, we have not observed appreciable difference in terms of threshold and timing of ERK response to the AC EF stimulation for low density of cells where individual cells are not in contact with each other (see Supplementary Figure S16). Therefore, we suggest the observed ERK activation is more likely to be related to a rather fast dynamic process at the cell membrane induced by the AC EF. The detailed molecular mechanism of the specific phosphorylation of EGFR by external AC EF as first demonstrated here still needs further investigation and modeling.

In summary, we have demonstrated a noninvasive and highly localized technique to precisely control ERK activation dynamics by bipolar AC EF pulses applied through microelectrodes with no Faradaic processes involved. ERK activity in multiple cells can be reproducibly synchronized and modulated in time. The ERK activation seemed to be specifically initiated by EF induced EGF-independent phosphorylation of EGFR and does not involve changes in pH, Ca2+, or ROS. Our work can serve as a unique platform for precise modulation of ERK activities and possibly other signaling pathways and can find wide biomedical applications to control cell behaviors through modulating signaling dynamics, which is difficult to achieve otherwise.

Methods.

MCF10A cells coexpressed with ERKAR3 and ERKTR-mCherry17 were cultured in customized chamber with microelectrode arrays fabricated on the bottom coverslip for EF stimulation during imaging. The cells were starved for 2 h in EGF-free medium before experiments. AC EF was generated by a NI 9269 module from National Instruments as the cells were imaged on an inverted microscope with an incubator chamber. Data processing and statistics were performed using Matlab (MathWorks) and Igor Pro (WaveMetrics). Detailed experiment materials and methods are provided in the Supporting Information.

Supplementary Material

Supporting Information
Supporting Information Movie S1
Download video file (1.3MB, avi)
Supporting Information Movie S2
Download video file (1.4MB, avi)
Supporting Information Movie S3
Download video file (4.1MB, avi)
Supporting Information Movie S4
Download video file (1.3MB, avi)

ACKNOWLEDGMENTS

Q.Q. and M.Z. acknowledge the support by the Air Force Office of Scientific Research under award number FA9550-16-1-0052. Q.Q. acknowledges the support by the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health under award number R21EB020822. M.Z. acknowledges the support by the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health under award number R21EB015737 and NIH R01EY019101. J.A acknowledges the support of the National Institutes of Health under award R01GM115650. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

ABBREVIATIONS

ERK

extracellular-signal-regulated kinase

AC

alternative current

EF

electric field

EGF

epidermal growth factor

FM

frequency modulation

ERKTR

ERK translocation reporter

DC

direct current

ROS

reactive oxygen species

TKI

tyrosine kinase inhibitor

JNK

c-Jun N-terminal kinase

TEP

transepithelial potential

Footnotes

Supporting Information

The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acs.nanolett.9b03411.

Details on estimation of impedance of microelectrode; estimation of cross-membrane potential at different AC EF frequencies; materials and methods; supportive figures on cell behavior image and analysis (PDF)

ERK activity of cells within 100 μm from the electrode response to 1 V 50 Hz AC EF (AVI)

ERK activity of cells more than 200 μm from the electrode response to 1 V 50 Hz AC EF (AVI) Repetitive 3 min EF stimulations showing synchronized ERK activation (AVI)

Fluorescence images of ERK activation triggered by AC EF from control group of no inhibitor and from cells with MEK inhibitor, Raf inhibitor, EGFR inhibitor blocking phosphorylation site, and EGFR antibody blocking EGF bind, respectively (AVI)

The authors declare no competing financial interest

REFERENCES

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information
Supporting Information Movie S1
Download video file (1.3MB, avi)
Supporting Information Movie S2
Download video file (1.4MB, avi)
Supporting Information Movie S3
Download video file (4.1MB, avi)
Supporting Information Movie S4
Download video file (1.3MB, avi)

RESOURCES